Medical Technology:

Implementing the Good Manufacturing Practices Regulation

T-PEMD-92-6: Published: Mar 25, 1992. Publicly Released: Mar 25, 1992.

Additional Materials:


Office of Public Affairs
(202) 512-4800

GAO discussed the Food and Drug Administration's Good Manufacturing Practices (GMP) Compliance Program for medical devices. GAO noted that: (1) in order to prevent the production and distribution of unsafe and ineffective medical devices, the GMP Compliance Program assesses manufacturers' implementation of the quality assurance requirements; (2) FDA continues to develop more stringent GMP quality assurance criteria and is working to harmonize GMP requirements with international quality assurance standards; (3) between fiscal years (FY) 1987 and 1989, the total number of device GMP inspections and the number of qualified inspections steadily declined, primarily due to the FDA prioritized inspection policy; (4) between FY 1987 and 1990, FDA untimely inspected one-third of the 323 manufacturers that initiated the first recall of a device; (5) even when FDA completes inspections on time, the inspections do not always identify or target GMP violations; (6) FDA recommended and reported compliance action on only about one-half of identified GMP compliance violations; (7) about one-half of the manufacturers that received two or more GMP compliance violations notices did not correct the violations from one inspection to the next; (8) inspectors' investigative capability is limited by FDA assignment policies and inadequate training on device technology; and (9) information on both medical device manufacturers and their devices is unreliable and incomplete.

Nov 13, 2018

Oct 30, 2018

Oct 23, 2018

Oct 15, 2018

Oct 1, 2018

Sep 28, 2018

Sep 17, 2018

Sep 13, 2018

Sep 10, 2018

Sep 6, 2018

Looking for more? Browse all our products here